Inventor
DAI YUJIA
US18 patents
⚠️ This page may combine multiple inventors who share the name “DAI YUJIA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBVIE INC
8 patentsUS9321764B2Apr 26, 2016
Dihydro-pyrrolopyridinone inhibitors
ABBVIE INC3 citations72
US9296741B2Mar 29, 2016
Bromodomain inhibitors
ABBVIE INC7 citations72
US10035800B2Jul 31, 2018
Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitors
ABBVIE INC3 citations70
US10131657B2Nov 20, 2018
Bromodomain inhibitors
ABBVIE INC2 citations69
US9957263B2May 1, 2018
Bromodomain inhibitors
ABBVIE INC3 citations69
US9932340B2Apr 3, 2018
Substituted indoles
ABBVIE INC7 citations67
US8940778B2Jan 27, 2015
Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
ABBVIE INC0 citations51
US8642776B2Feb 4, 2014
Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
ABBVIE INC0 citations51
ABBOTT LAB
6 patentsUS7297709B2Nov 20, 2007
Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
ABBOTT LAB92 citations98
US6294573B1Sep 25, 2001
Reverse hydroxamate inhibitors of matrix metalloproteinases
ABBOTT LAB131 citations97
US6235786B1May 22, 2001
Reverse hydroxamate inhibitors of matrix metalloproteinases
ABBOTT LAB103 citations96
US7812166B2Oct 12, 2010
Kinase inhibitors
ABBOTT LAB15 citations83
US7598283B2Oct 6, 2009
Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
ABBOTT LAB5 citations73
US7560552B2Jul 14, 2009
Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
ABBOTT LAB3 citations62